Skip to content

Comparison of 3 different acupoint combinations of acupuncture effect on COPD:A multicenter randomised sham-controlled trial

MDT programme of State Administration of Traditional Chinese Medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005302
Enrollment
Unknown
Registered
2021-09-11
Start date
2021-11-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine, Jinniu District, Chengdu, Sichuan Province, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Participants who meet all the following conditions will be considered for registration. The selection criteria are as follows: (1) Patients diagnosed with COPD have stable condition without acute exacerbation in the past 4 weeks; (2) Pulmonary function classification of the severity of airflow limitation: GOLD1-3 (3) Symptom assessment and acute exacerbation risk: Groups A and B; (4) 40=age=80 years old, both male and female; (5) No history of infection or worsening of respiratory symptoms, no drug changes and no edema symptoms within 3 months before the start of the study; (6) Patients who can walk independently; (7) Patients who have not undergone pulmonary rehabilitation in the past 6 months; (8) Good compliance, willing to cooperate with the research, and the patient signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe cardio-cerebrovascular, nervous system, blood system, immune system, digestive system, thyroid dysfunction, chronic liver and kidney insufficiency, and malignant tumors; (2) Other concomitant active or clinically significant respiratory diseases that have a significant impact on the research: subjects such as active tuberculosis, bronchiectasis, pulmonary hypertension, interstitial pulmonary diseases or other active lung diseases; (3) Those who use long-term oxygen therapy (oxygen therapy time> 15h/d) or mechanical ventilation; (4) Those who are not satisfied with blood pressure and blood sugar control; (5) Those with a history of mental illness, mental retardation, and mobility impairment; (6) Pregnant or lactating women; (7) Participate in other clinical trials within the past 6 months or at the same time. Note: Patients who meet any of the above items will be excluded.

Design outcomes

Primary

MeasureTime frame
FEV1;Borg dyspnea scale;

Secondary

MeasureTime frame
COPD assessment test;modified british medical research council;6-minute walk distance;

Countries

China

Contacts

Public ContactFanrong Liang

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine

acuresearch@126.com13608058216

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026